A modern approach to treatment, as well as medical research, requires a lot of data about a patient for a better outcome. More profound knowledge about the human body, genetic, phenotypic, or psychosocial characteristics could ensure precise identification of patient risk factors, early diagnosis of a disease, or treatment targeting. One of our clients decided to use medical data to build patient similarity networks to define the safety of hydroxychloroquine, a drug to treat rheumatoid arthritis. We determined whether it is safe to use hydroxychloroquine (alone and in combination with azithromycin) via building patient similarity networks.

Challenge

Solution

Impact

Tech Stack

Hydroxychloroquine plus azithromycin in the short term poses a risk of cardiovascular mortality and heart failure. So, our study shows that hydroxychloroquine treatment should be assigned carefully.